United States · Series B startup

Who invested in Senhwa Biosciences

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$17Mraised across 1 round since 2013, from 1 source

Latest round
Series B, $17MDec 2013
Investors
4
See who backed them

The rounds

  1. Dec 2013
    Series B$17M

    Reported by pehub.com

Everyone who backed them

Morningside GroupVC firm1round
WI Harper GroupVC firm1round
H&Q Asia PacificVC firm1round
China Investment & Developmentno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Senhwa Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Sanderling VenturesVC firmPer its own site

Quick answers about Senhwa Biosciences

Who invested in Senhwa Biosciences?

Senhwa Biosciences's investors include Morningside Group, WI Harper Group, H&Q Asia Pacific and China Investment & Development.

How much has Senhwa Biosciences raised?

Senhwa Biosciences has raised $17M across 1 round since 2013.

When did Senhwa Biosciences last raise?

Senhwa Biosciences's most recent round was a Series B of $17M in Dec 2013.

What was Senhwa Biosciences's biggest round?

Its most recent round, $17M in Dec 2013, is also its largest on record.

Who backed Senhwa Biosciences first?

Senhwa Biosciences's first round on record, in Dec 2013, was backed by Morningside Group, WI Harper Group and H&Q Asia Pacific and 1 others.

What stage is Senhwa Biosciences at?

Senhwa Biosciences's latest named round is a Series B, in Dec 2013.

Where is Senhwa Biosciences based?

Senhwa Biosciences is based in the United States.

Companies like Senhwa Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.